170 related articles for article (PubMed ID: 32062803)
1. Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer.
Kawwass JF; Shandley LM; Boulet SL; Hipp HS
J Assist Reprod Genet; 2020 Apr; 37(4):883-890. PubMed ID: 32062803
[TBL] [Abstract][Full Text] [Related]
2. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection.
Johnston M; Richings NM; Leung A; Sakkas D; Catt S
Hum Reprod; 2021 Feb; 36(3):624-635. PubMed ID: 33367704
[TBL] [Abstract][Full Text] [Related]
3. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
4. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
Walker Z; Lanes A; Ginsburg E
Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
[TBL] [Abstract][Full Text] [Related]
5. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
6. Oocyte Cryopreservation in Adolescent Women.
Hipp HS; Shandley LM; Schirmer DA; McKenzie L; Kawwass JF
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):377-382. PubMed ID: 30904628
[TBL] [Abstract][Full Text] [Related]
7. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
8. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
9. Added Benefit of Immature Oocyte Maturation for Fertility Preservation in Women with Malignancy.
Cohen Y; Tannus S; Volodarsky-Perel A; Son WY; Tulandi T; Buckett W
Reprod Sci; 2020 Dec; 27(12):2257-2264. PubMed ID: 32617879
[TBL] [Abstract][Full Text] [Related]
10. The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.
Maslow BL; Guarnaccia M; Stefanacci C; Ramirez L; Klein JU
Hum Reprod; 2020 May; 35(5):1054-1060. PubMed ID: 32406915
[TBL] [Abstract][Full Text] [Related]
11. Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey.
Kasaven LS; Mitra A; Ostrysz P; Theodorou E; Murugesu S; Yazbek J; Bracewell-Milnes T; Ben Nagi J; Jones BP; Saso S
Hum Reprod; 2023 Dec; 38(12):2478-2488. PubMed ID: 37816663
[TBL] [Abstract][Full Text] [Related]
12. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
13. Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.
Schon SB; Shapiro M; Gracia C; Senapati S
J Assist Reprod Genet; 2017 Sep; 34(9):1207-1215. PubMed ID: 28656539
[TBL] [Abstract][Full Text] [Related]
14. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
[TBL] [Abstract][Full Text] [Related]
15. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
[TBL] [Abstract][Full Text] [Related]
16. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
17. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
18. Oocyte Cryopreservation: A 9-Year Single-Centre Experience.
Harjee R; Chen J; Caudle J; Ouhibi N; Edsall S; Smrz J; Lardizabal J; Abdelghadir S; Nakhuda G
J Obstet Gynaecol Can; 2022 Dec; 44(12):1271-1278. PubMed ID: 36272695
[TBL] [Abstract][Full Text] [Related]
19. The use of oocyte cryopreservation for fertility preservation in patients with sex chromosome disorders: a case series describing outcomes.
Martel RA; Blakemore JK; Fino ME
J Assist Reprod Genet; 2022 May; 39(5):1143-1153. PubMed ID: 35320443
[TBL] [Abstract][Full Text] [Related]
20. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
